High burden of invasive Streptococcus agalactiae disease in South African infants

Shabir A Madhi1, Kholeka Radebe, Heather Crewe-Brown

  • 1NHLS/Wits/MRC Pneumococcal Diseases Research Unit, University of the Witswaterand, Johannesburg, South Africa. shabirm@mail.saimr.wits.ac.za

Insights

Invasive Streptococcus agalactiae (GBS) disease is a significant threat to South African infants, with high mortality rates. Current prevention strategies for GBS disease require urgent reassessment.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Epidemiology

Background:

  • Invasive Streptococcus agalactiae (Group B Streptococcus - GBS) disease poses a substantial public health challenge in South African infants.
  • Understanding the epidemiology of GBS disease is crucial for developing effective prevention and treatment strategies.

Purpose of the Study:

  • To evaluate the epidemiology of invasive GBS disease in South African children.
  • To identify risk factors for mortality and common serotypes associated with GBS infection.

Main Methods:

  • Retrospective review of medical records of 208 children diagnosed with GBS between January 1997 and December 1999.
  • Classification of GBS cases into early-onset disease (EOD), late-onset disease (LOD), and childhood-onset disease (COD).
  • Analysis of mortality rates, risk factors, and serotype distribution.

Main Results:

  • GBS disease presented as EOD (63%), LOD (31.7%), and COD (5.3%).
  • The incidence of EOD and LOD was 2.06 and 1 per 1000 live births, respectively, with mortality rates of 19.8% and 13.6%.
  • Septic shock, prematurity, low birthweight, and low leukocyte count were significant risk factors for mortality. Serotypes III and Ia were predominant.

Conclusions:

  • Invasive GBS disease is highly prevalent in South African infants, necessitating a re-evaluation of current control measures.
  • Specific serotypes, particularly III and Ia, are major contributors to invasive GBS disease.
  • Targeted interventions and reconsidered public health strategies are essential to reduce the burden of GBS infection.

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...